Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

RPX Corp (RPXC): High Margins and a Nice Cash Stockpile

Page 1 of 2

San Francisco-based RPX Corp (NASDAQ:RPXC) recently announced fourth-quarter 2012 earnings that exceeded most analysts’ expectations and hinted at a period of potential growth for the small patent-protection firm. The company’s profits and revenues both grew at a healthy clip. While its gross margin decreased by a moderate amount, both its operating margins and net margins exhibited encouraging growth.

Even more importantly, the company is sitting on a massive cash hoard. Its cash per share metric currently sits near $4. Meanwhile, its liquid capital reserves of around $200 million are equal to about 30 percent of its total market capitalization. What’s more, RPX Corp (NASDAQ:RPXC) is currently devoid of debt, despite an ongoing $500 million patent-buying spree. As such, the company is in an enviable financial position and could soon put its cash reserves to work.

RPX Corp (NASDAQ:RPXC)About RPX Corporation

RPX Corporation is a specialized patent-management company that does business with inventors and commercial clients in North America and Eurasia. The company provides analysis, research and data for patent holders and applicants, as well as detailed future market analysis. However, its main services involve the wholesale purchase and leasing of certain types of valuable patents. These services are designed to reduce risk for the end-users of patents while fairly compensating their holders. RPX Corp (NASDAQ:RPXC)’s patent solutions also provide significant protection against common patent-infringement claims. Most of its clients hail from the highly-competitive technology sector. The company employs just 125 people in the Bay Area and had an EBITDA of $144.9 million on revenues of $197.7 million in 2012.

Other Players and Competitors

RPX Corp (NASDAQ:RPXC) is one of few publicly-traded patent risk management companies that operates in the United States. However, it actually operates in a fairly crowded space. In the US, Acacia Research Corporation (NASDAQ:ACTG). is in the technology patent arena.  Acacia licenses and enforces patents for themselves and their clients.  They own about 250 patents in the US. Compared to RPX, Acacia is quite similar from a cash and profitability point of view.  Acacia has a large cash stockpile and a profit margin of 23%.  Both companies have no debt and a growing bottom line.

Since patent risk management requires little more than a steady flow of capital and intelligent individuals who can accurately judge and assign risk, privately-held competitors are fully capable of posing a significant threat to RPX’s business model. In fact, Guggenheim investments operates an ETF, OTP (NYSEMKT:OTP), that is specifically designed to reward investors for the performance of the patent portfolio of one of RPX’s main rivals.  OTP invests in companies like Microsoft and IBM in order to benefit from their long term growth due to their valuable patents.  The NAV of this ETF is up over 11% so far in 2013.

However, RPX’s size and reputation provides it with a key advantage. The company has several high-profile risk-management partners, including Aon PLC (NYSE:AON). Aon, with its over $11 billion in revenue and a growing profit margin, is the kind of client RPX needs to retain.  Clients like Aon can provide the company with a steady stream of revenue and smooth out the rockiness of the economic cycle.

Ample Cash, Little Debt

Like many other small-cap stocks that currently trade at discounts to their book and tangible values, RPX Corp (NASDAQ:RPXC) has an ample amount of cash and virtually no long-term debt. Although the company’s P/E ratio of 17 is not particularly low, it is difficult to determine the proper multiples at which it should trade. Since most of its clients are technology companies that often trade at outrageous valuations due to expectations of future growth, it may be helpful to judge RPX Corp (NASDAQ:RPXC) by the same yardstick.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!